Effectiveness of Platelet Rich Fibrin (PRF) Compared with Conventional Therapy Toward Wound Dehiscence of Post-Operative Laparotomy by Laqif, A et al.
ICO-HELICS
The 1st International Conference on Health, Technology and Life Sciences
Volume 2019
Conference Paper
Effectiveness of Platelet Rich Fibrin (PRF)
Compared with Conventional Therapy Toward
Wound Dehiscence of Post-Operative
Laparotomy
Abdurahman Laqif, Nur Aini Fatah, and Supriyadi Hari Respati
Department of Obstetrics and Gynecology Faculty of Medicine of Universitas Sebelas Maret/ Dr.
Moewardi General Hospital Surakarta
Abstract
Objective: To compare the effectiveness of Platelet Rich Fibrin (PRF) and conventional
therapy toward wound dehiscence of post-operative laparotomy in the Department of
Obstetrics and Gynecology at Moewardi hospital.
Methods: This was a cross-sectional study conducted from September to December
2017 on obstetrics and gynecology post-laparotomy patients undergoing subtotal
wound dehiscence in the Department of Obstetrics and Gynecology at Moewardi
hospital from2013 to 2017. Theywere divided into 2 groups, group 1 consisted of patients
with subtotal wound dehiscence after obstetric and gynecological operation receiving
conventional non-operative therapy, and group 2 was those having subtotal wound
dehiscence after obstetrics and the gynecological operation receiving non-operative
treatment with PRF. The data were analyzed using the T-test, performed by SPSS
(Software Package for Social Science).
Results: There were 15 subjects in each group meeting the inclusion and exclusion
criteria for both case and control groups. The statistical test showed that the average
duration of wound healing in control group (12.60 about 2.58) was longer than in PRF
group (7.0 about 3.52) with the significance of value p= 0.001 (p<0.05). The PRF group
spent less cost (IDR 4.511.362 ± 2.977.934) compared with the conventional therapy
group (IDR 12.540.735 ± 8.227.433) with p = 0.001 (p<0.05).
Conclusions: Patients with PRF therapy had faster-wound healing duration, and the
result was statistically significant with p=0.001 (p<0.05). PRF therapy also had more
cost-effectiveness compared with conventional therapy with p=0.001(p<0.05).
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1. Background
Wound dehiscence after laparotomy remains a severe surgical complication problem
and includes 1-3% of patients undergoing abdominal surgery. The occurrence of post-
laparotomy wound dehiscence is related to conditions such as anemia, hypoalbumine-
mia, malnutrition, malignancy, obesity, diabetes, geriatrics, as well as specific surgical
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procedures such as obstetric and gynecological surgery (obstetrical and gynecological
laparotomy) [1]. Current dehiscence management is divided into non-operative or con-
servative and operative management. Platelet Rich Fibrin (PRF) is a breakthrough for
non-operative therapy in patients with surgical dehiscence. PRF contains many growth
factors needed for wound healing [2]. PRF contains over 30 bioactive proteins, growth
factors, various cytokines, and chemokines that play an essential role in wound healing,
acute tissue response to trauma, and involves in some of the physiological processes of
the cell, such as growth differentiation, and cell replication [3]. PRF is autologous, so it is
relatively safe and does not pose a risk of allergic or infectious disease. This study aimed
to determine the effectiveness of wound healing in wound dehiscence of obstetric and
gynecologic laparotomy with PRF treatment compared to conventional non-operative
methods.
2. Subject and Methods
This was a cross-sectional study conducted in patients who admitted to Obstetric and
Gynecology clinic of Dr. Moewardi General Hospital from September to December
2017 and underwent subtotal wound dehiscence following obstetric and gynecological
laparotomy in the last 5 years. Subjects were divided into two groups: the control group
was given conventional non-operative method while the treatment group was using
PRF treatment and all the subjects met inclusion and exclusion criteria. Inclusion criteria
including post-obstetric and gynecologic laparotomy dehiscencewith aminimumwound
length of 3 cm with wound depth up to the fascia of musculus rectus abdominis, while
exclusion criteria including post-obstetric and gynecologic, obstetric deformation com-
plications with depth to peritoneum parietal, complications of laparoscopic dehiscence
wounds were present such as infection, worsening of the patient’s general condition,
and also the patient’s refusal to continue the study. The sample size was taken with fixed
disease sampling method, and Patient has first assessed the condition of the wound
then divided into two groups. In the control group using conventional methods, wound
dressing was performed by cleaning the wound with 0.9% sterile saline (NaCl) followed
by wound closure using sterile gauze. In the PRF therapy group, wound dressing was
performed by cleaning the wound with 0.9% sterile saline (NaCl) followed by PRF
gel and then wound closure by sterile gauze. Evaluation of wound conditions were
3 days after treatment for each group, followed by the retrieval and data processing
and conducted statistical analysis. The difference among 2 groups was considered
statistically significant if p value <0.05.
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3. Results
The subjects of the study were patients with subtotal wound dehiscence after obstetric
and gynecologic laparotomy in Dr. Moewardi Hospital. Subjects were divided into 2
groups, each group consisted of 15 patients. Each group’s characteristics is shown in
Table 1 below:
Table 1: Description of Data Subject of the Study.
Variable N Min Max Mean SD
Maternal Age (Year)
Control group 15 26,00 43,00 36.06 5.22
PRF group 15 25,00 43,00 35.38 5.02
BMI
Control group 15 20,00 36,50 22,36 4,13
PRF group 15 19,00 24,00 21,13 1,46
Hemoglobin
Control group 15 9,30 12,00 11,47 3,03
PRF group 15 9,30 11,90 10,51 0,75
Albumin
Control group 15 2,50 4,00 3,37 0,37
PRF group 15 3,00 4,10 3.56 0,35
Blood Glucose
Control group 15 80,00 112,00 95,00 10,336
PRF group 15 68,00 120,00 95,00 13,824
Working status Work Do Not Work
Control group 15 7 8
PRF group 15 6 9
Statistical analysis was done to determine the normality and the homogeneity of the
data, continued with bivariate analysis of each characteristic above. We found that all
the above variables were homogeneous and there were no significant differences.
The outcome of wound healing between the control group and PRF is seen in the
average time of wound healing as shown in Table 2 below:
Table 2: Wound healing time between the control group and PRF group.
Variable Group N Mean (days) p
Wound healing time Control group 15 12.60±2.58 0.001*
PRF group 15 7.0±3.52
* Significance value p < 0.05
Table 2 shows that the average length of wound healing in the control group was
longer than PRF group (12.60±2.58 vs 7.0±3.52). Statistical analysis using the normality
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data test by Saphiro-Wilk test on the duration of wound healing for the control group
and the PRF group showed p= 0.050 and p= 0.069 (p sig> 0.05), which means that data
is normally distributed. The homogeneity test of Lavene showed p= 0.23 (p sig >0.05),
meaning that the data is homogeneous. The statistical difference in wound healing time
in both groups then analyzed using unpaired t-test. It showed that there was a very
significant difference (p= 0.001) between two groups.
Table 3: Multivariate Dependent Regression independent Age, BMI, HB, Albumin, Blood Glucose Serum




Umur 10,169 -0,064 0,950 Not significant
Body mass index (BMI) -0,010 0,274 0,786 Not significant
Hemoglobin (Hb) 0,058 1,461 0,157 Not significant
Albumin 0,462 0,102 0,920 Variable
Blood glucose 0,181 0,122 0,904 Variabele
PRF 0,008 -3,699 0,001 Signifiant
Value of F = 4,367 p Sig = 0,004 (Significant)
F test on double linear regression which aimed to test independent variable (age,
BMI, Hb, albumin, blood glucose, PRF) on regression model shows that all independent
variables had a simultaneous effect on the dependent variable (wound healing time).
The costs of therapy on patients undergoing wound dehiscence after obstetric and
gynecologic laparotomy in Dr. Moewardi Hospital over the past five years (2013-2017)
were also analyzed in both control group and PRF group, the cost data obtained from
the medical record, with an average cost as follows:
Table 4: Average Cost of therapy on the control group and PRF group.
Variable Group N Average cost (days) p
The average cost of
therapy
Conventional 15 IDR 12.540.735±8.227.433 0.001*
PRF 15 IDR 4.511.362±2.977.934
* Significance value p < 0.05
From Table 3 it was found that the average cost of therapy in conventional group
patients was more expensive than the PRF group (12.540.735 ± 8.227.433v s 4.511.362
± 2.977.934) and it is statistically significant (p=0.001). Thus PRF therapy can be used as
a cheaper therapy.
Multivariate test by using confidence interval 95% and α=0.05 showed that total
wound healing cost between conventional and PRF group was not affected by external
variables where p=0.071 (p<0,05).
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Table 5: A multivariate test of wound healing average cost between conventional and control group.
Variables Sexual Disorder
OR CI 95 % P
Occupational status .785 -4362335.260 9647326.682 .442
Age .944 -345836.946 920818.425 .356
Wound healing time .349 -718962.486 1008476.604 .731
Hb -.265 -1542027.120 1193814.280 .794
BMI 1.408 -293029.694 1522950.983 .174
Albumin .294 -6305767.124 8383344.365 .772
Blood Glucose serum .202 -257044.011 312501.243 .841
Group -1.809 -15944929.811 1107558.516 .085
* Significance p < 0.05
4. Discussion
From the result of the bivariate test conducted on the research variables in both groups
of PRF, it showed that age, BMI, hemoglobin, albumin, and blood glucose are not statis-
tically different (or homogeneous) with p> 0.05. The average duration of wound healing
appears to be longer in the conventional group (12.60 ± 2.58 days), compared to PRF
group (7.00 ± 3.52 days). The unpaired t-test analysis using a 95% confidence interval
and α= 0.05 proved that the difference in wound healing among the conventional group
and the PRF group was statistically significant (p= 0.001).
The Mann Whitney’s test analysis using 95% confidence interval and α= 0.05 proved
that there was a very significant difference (p= 0.001) in total cost of wound healing
between the conventional group and PRF group. Multivariate test using 95% confidence
interval and α = 0.05 showed that the existing external variable did not affect total wound
healing cost between conventional group and PRF group (p= 0.071; p> 0.05).
Plasma Rich Fibrinogen is a blood plasma contain rich of fibrin and thrombocyte
concentration 3-5 times above normal value (platelet concentration in whole blood) [4].
Another literature mentioned that thrombocyte concentrations in PRF were 2-8 times
higher comparedwith average values [5]. The high concentration of platelets and various
growth factors in PRF has made this agent applicable in many branches of medicine, i.e.,
oral surgery, plastic surgery, craniofacial surgery, cardiac surgery, orthopedics, neurol-
ogy, sports medicine, and dermatology [6].
Plasma Rich Fibrinogen has various growth factors that are needed in wound healing.
When platelets in PRF are activated by thrombin, thrombocytes release growth factors
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and other substances that serve to accelerate wound healing by increasing cell prolif-
eration, matrix formation, osteoid production, tissue healing, angiogenesis, and colla-
gen synthesis. Plasma Rich Fibrinogen works by degranulation of α-granules present in
platelets containing growth factors [7].
These growth factors help wound healing by attracting cells in a newly formed matrix
and trigger cell division. Plasma Rich Fibrinogen has several advantages such as simple,
safe, low cost, and clinical effectiveness so that PRF can be an ideal therapy for the
treatment of chronicwounds [8]. PlasmaRich Fibrinogen not only releases growth factors
in high concentrations but also has antimicrobial properties that can prevent infection
because it contains leukocytes [9].
Plasma Rich Fibrinogen has long been used in healing wounds and soft tissue under-
neath. The use of PRF in the field of skin surgery and cosmetic dermatology is also pro-
liferating [10]. Wound healing is a complex event involving various cells, and biochemical
mediators, one of the critical part were platelets. In response to tissue damage, activated
platelets will form platelet plugs and release various growth factors [11]. These growth
factors play an essential role in the various phases of wound healing (the inflammatory
phase up to the remodeling phase) [12]. Platelets also store other bioactive proteins, such
as the enzymematrix metalloproteinase (MMP), coagulation factors, chemotactic factors,
adhesion molecules, vasoactive substances, as well as some bactericidal and fungicidal
proteins that also play an active role in the wound healing process. Invitro, there is a
relationship between platelet concentration with mesenchymal stem cell proliferation,
fibroblast proliferation, and type I collagen production. It supports the role of PRF to
accelerate wound healing [13].
Platelet Derived Growth Factor (PDGF) functions in the stimulation of fibroblasts,
chemotactic, TGF-β stimulation, collagen production, increased proteoglycan synthesis.
Transforming Growth Factor Beta (TGF-β) functions to modulate the proliferation of
fibroblasts, formation of extracellular matrix, increase collagen production by fibroblasts,
neutrophil chemotactic factors, and macrophages, while Basic Fibroblast Growth Factor
(bFGF) plays a role in collagen production, stimulation of angiogenesis, and myoblast
proliferation [11].
In this study, besides healing wounds more quickly, PRF also has more affordable cost
therapy than conventional therapy. Faster healing time affects hospitalization care time in
the hospital, thus reducing cost therapy. Thus, PRF can be a practical and cost-effective
treatment option.
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5. Conclusion
There was a significant difference in wound healing time of wound dehiscence patients
after obstetric and gynecological laparotomy using PRF therapy compared to conven-
tional methods, where PRF group has shorter wound healing time than the control group.
Also, PRF therapy is cheaper than conventional therapy.
6. Recommendation
Further study is needed by involving more subjects so it will strengthen the validity and
the study could be used as a comparison.
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